Cord blood serum affects T cells ability to produce and respond to IL-2

Cytokine

Volumn 22, Issue 1-2, 2003, Pages 42-49

  Bogunia Kubik, Katarzyna ^a,b   Natarajan, Prasad ^a   Brown, Sarah ^a   Wolley, Joanna ^a   Alcocer, Maria ^a   Fallen, Paul R ^a   Madrigal, J Alejandro ^a,c   Cohen, Shara B A ^a,c,d  

^a ANTHONY NOLAN RESEARCH INSTITUTE   (United Kingdom)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d UK Cord Blood Immunology Group   (United Kingdom)

Author keywords

CB serum; Interleukin 2; T cells

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD28; MONOCLONAL ANTIBODY CD3; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL LINE; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLOGY; DRUG EFFECT; FETUS BLOOD; HUMAN; HUMAN CELL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; METABOLISM; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UMBILICAL CORD BLOOD;

EID: 0141639658     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-4666(03)00109-1     Document Type: Article

References (43)

1. Mellor A.L., Munn D.H. Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppression. Annu Rev Immunol. 18:2000;367-391.
2. Suciu-Foca N., Reed E., Rohowsky C., Kung P., King D.W. Anti-idiotypic antibodies to anti-HLA receptors induced by pregnancy. Proc Natl Acad Sci USA. 80:1983;830-834.
3. Tafuri A., Alferink J., Moller P., Hammerling G.J., Arnold B. T cell awareness of paternal alloantigens during pregnancy. Science. 270:1995;630-633.
4. Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol Today. 18:1997;478-482.
5. Munn D.H., Zhou M., Attwood J.T., Bondarev I., Conway S.J., Marshall B., et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science. 281:1998;1191-1193.
6. Raghupathy R. Pregnancy: success and failure within the Th1/Th2/Th3 paradigm. Semin Immunol. 13:2001;219-227.
7. Harris D.T., Schumacher M.J., Locascio J., Besencon F.J., Olson G.B., Deluca D., et al. Phenotypical and functional immaturity of human umbilical cord blood T lymphocytes. Proc Natl Acad Sci USA. 89:1992;10006-10010.
8. Chalmers I.M.H., Janossy G., Contreras M., Navarrete C. Intracellular cytokine profile of cord and adult blood lymphocytes. Blood. 92:1998;11-18.
9. Hassan J., Reen D. Cord blood CD4+CD45RA+ T cells achieve a lower magnitude of activation when compared with their adult counterparts. Immunology. 90:1997;397-401.
10. Bertotto A., Gerli R., Lanfrancone L., Crupi S., Arcangeli C., Cernetti C., et al. Activation of cord T lymphocytes II. Cellular and molecular analysis of the defective response induced by anti-CD3 monoclonal antibody . Cell Immunol. 127:1990;247-259.
11. Gerli R., Bertotto A., Crupi S., Arcangeli C., Marinelli I., Spinozzi F., et al. Activation of cord T lymphocytes I. Evidence for a defective T cell mitogenesis induced through the CD2 molecule . J Immunol. 142:1989;2583-2589.
12. Lucivero G., Dalla Mora L., Bresciano E., Loria M.P., Pezone L., Mancino D. Functional characteristics of cord blood T lymphocytes after lectin and anti-CD3 stimulation. Differences in the way T cells express activation molecules and proliferate. Int J Clin Lab Res. 26:1996;255-261.
13. Hassan J., O Neill S., O Neill L.A., Pattison U., Reen D.J. Signalling via CD28 of human naive neonatal T lymphocytes. Clin Exp Immunol. 102:1995;192-198.
14. Pirenne-Ansart H., Paillard F., De Groote D., Eljaafari A., Le Gac S., Blot P., et al. Defective cytokine expression but adult-type T-cell receptor, CD8, and p56lck modulation in CD3- or CD2-activated T cells from neonates. Pediatr Res. 37:1995;64-69.
15. Lewis D.B., Yu C.C., Meyer J., English B.K., Kahn S.J., Wilson C.B. Cellular and molecular mechanisms for reduced interleukin 4 and interferon-gamma production by neonatal T cells. J Clin Invest. 87:1991;194-202.
16. Sautois B., Fillet G., Beguin Y. Comparative cytokine production by in vitro stimulated mononucleated cells from cord blood and adult blood. Exp Hematol. 25:1997;103-108.
17. Kruse A., Rink L., Rutenfranz I., Kolanczyk B., Kirchner H. Interferon and lymphokine production by human placental and cord blood cells. J Interferon Cytokine Res. 12:1992;113-117.
18. Kruse A., Neustock P., Reuter M., Kirchner H. T-cell surface molecule expression and interferon-gamma production in human cord blood. J Interferon Cytokine Res. 13:1993;221-225.
19. Risdon G., Gaddy J., Horie M., Broxmeyer H.E. Alloantigen priming induces a state of unresponsiveness in human umbilical cord blood T cells. Proc Natl Acad Sci USA. 92:1995;2413-2417.
20. Bogunia-Kubik K., Perez-Cruz I., Fallen P.R., Madrigal J.A., Cohen S.B.A. Cord blood lymphocytes have a low frequency of cytokine producing T cells due to a high threshold for activation. Immunol Lett. 72:2000;145-146.
21. Perez-Cruz I., Bogunia-Kubik K., Cohen S.B.A. Cord blood cytokines. Cohen S.B.A., Madrigal J.A., Gluckman E., Rubinstein P. CB characteristics: role in stem cell transplantation. 2000;75-93 M. Dunitz, London.
22. Fallen P., Cohen S.B.A. Cord blood T cells. Cohen S.B.A., Madrigal J.A., Gluckman E., Rubinstein P. CB characteristics: role in stem cell transplantation. 2000;39-59 M. Dunitz, London.
23. Cohen S.B.A., Morgan C.L., Perandin F., Martinez B., Madrigal J.A. Cord blood serum does not increase lymphocyte responses in comparison to adult serum. Hum Immunol. 61:2000;111-114.
24. Cohen S.B.A., Woolley J., Bogunia-Kubik K., Natarajan P., Kotecha R., Belaramani L., et al. Macrophage colony stimulating factor (M-CSF) within cord blood sera may be partially responsible for the reduced proliferation of cord blood T cells. Eur Cytokine Netw. 11:2000;608-617.
25. Webb B.J., Bochan M.R., Montel A., Padilla L.M., Brahmi Z. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum. Cell Immunol. 159:1994;246-261.
26. Hata T., Kawamura T., Fujiwaki R., Aoki S., Hata K., Inada K. Interleukin-4, interleukin-10, and soluble tumor necrosis factor receptors in cord blood. Gynecol Obstet Invest. 43:1997;155-157.
27. Westgren M., Ek S., Remberger M., Ringden O., Stangengberg M. Cytokines in fetal blood and amniotic fluid in Rh-immunized pregnancies. Obstet Gynecol. 86:1995;209-213.
28. Seino Y., Ishida M., Yamaoka K., Ishii T., Hiejima T., Ikehara C., et al. Serum calcium regulating hormones in the perinatal period. Calcif Tissue Int. 34:1982;131-135.
29. Sulovic V., Siljak B., Sinadinovic J. Serum T4, T3, r-T3, TSH and Tg levels in cord blood and maternal circulation at the time of delivery. Exp Clin Endocrinol. 83:1984;256-262.
30. Krauss T., Azab H., Dietrich M., Augustin H.G. Fetal plasma levels of circulating endothelial cell adhesion molecules in normal and preeclamptic pregnancies. Eur J Obstet Gynecol Reprod Biol. 78:1998;41-45.
31. Cohen S.B.A., Parry S.L., Feldmann M., Foxwell B. Autocrine and paracrine regulation of human IL-10 production. J Immunol. 158:1997;5596-5602.
32. Harris D.T., LoCascio J., Besencon F.J. Analysis of the alloreactive capacity of human umbilical cord blood: implications for graft-versus-host disease. Bone Marrow Transplant. 14:1994;545-553.
33. Raghupathy R., Khan S.F., Syamasundar P.V., Bansal P., Azizieh F. A placenta-derived suppressor factor with a T-cell bias. Am J Reprod Immunol. 42:1999;205-218.
34. Rizzo A.G., Ovak G.M., Donovan R.M., Chen P.B., Mookerjee B.K., Pauly J.L. Activation and long-term proliferation of human cord blood T cells with human recombinant interleukin-2. J Clin Lab Immunol. 24:1987;1-9.
35. Fairfax C.A., Borzy M.S. Interleukin 2 production, proliferative response, and receptor expression by cord blood mononuclear cells. J Clin Lab Immunol. 27:1988;63-67.
36. Wotton D., Higgins J.A., O'Hehir R.E., Lamb J.R., Lake R.A. Differential induction of NF-AT complex during restimulation and the induction of T cell anaegy. Human Immunol. 42:1995;95-102.
37. Madrigal J.A., Cohen S.B.A., Gluckman E., Charron D.J. Does cord blood transplantation result in lower graft-versus-host disease? It takes more than two to Tango. Hum Immunol. 56:1997;1-5.
38. Eisner M.D., August C.S. Impact of donor and recipient characteristics on the development of acute and chronic graft-versus-host disease following pediatric bone marrow transplantation. Bone Marrow Transplant. 15:1995;663-668.
39. Ferrara J.L. Cytokine dysregulation as a mechanism of graft versus host disease. Curr Opin Immunol. 5:1993;794-799.
40. Dominguez E., Madrigal J.A., Cohen S.B.A. Foetal natural killer cell function is suppressed. Immunology. 94:1998;109-114.
41. Cohen S.B.A., Crawley J.B., Kahan M.C., Feldmann M., Foxwell B. IL-10 rescues T cells from apoptotic cell death: association with an upregulation of Bcl-2. Immunology. 92:1997;1-5.
42. Zamauskaite A., Perez-Cruz I., Yacoob M.M., Madrigal J.A., Cohen S.B.A. Effect of renal dialysis therapy on modality on T cell cytokine production. Nephrol Dial Transplant. 14:1999;49-55.
43. Collins D.P. Cytokine and cytokine receptor expression as a biological indicator of immune activation: important considerations in the development of in vitro model systems. J Immunol Meth. 243:2000;125-145.